EW - Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems.
As of Jun 30, 2026: spot at $90.34, ATM IV 26.6%, max pain $85.00, net GEX $4.0M.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Market Cap
- $52.27B
- P/E Ratio
- 48.11
- Beta
- 0.87
- 52-Week Range
- 72.3-92.46
- CEO
- Bernard J. Zovighian
- Employees
- 15,800
- IPO Date
- Mar 27, 2000
- Exchange
- NYSE
What EW Looks Like to Options Traders Today
IV rank of 21.5% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($4.0M) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.038) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The EW overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked EW overview questions
- What is EW?
- EW is the ticker symbol for Edwards Lifesciences Corporation, a listed security. Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Listed on NYSE. EW is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the EW options snapshot look like today?
- As of Jun 30, 2026, the EW options snapshot shows spot at $90.34, ATM IV 26.6%, IV rank 21.5%, max pain $85.00, net GEX $4.0M, expected move 7.63%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are EW's key statistics?
- Edwards Lifesciences Corporation (EW) carries a market capitalization of $52.27B, trailing P/E ratio of 48.11, beta of 0.87 relative to the broader market, 52-week range of 72.3-92.46. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does EW belong to?
- Edwards Lifesciences Corporation operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare EW's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the EW data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).